Group Threatens Suit against Bayer for False Advertising Related to One a Day Vitamins
Trish McKernan, Bayer’s global spokeswoman, responded that the company stands behind that claims that it has made. She stated, “The selenium claims are made by an FDA-approved qualified health claim. We regularly review the evidence, and we change our claims if necessitated. The emerging science hasn’t compelled us to change our claims, and the FDA claim is intact.”
Bayer promotes One A Day Men’s 50+ Advantage and One A Day Men’s Health Formula multivitamins on package labels, TV and radio ads and on its Web site. In its promotions, the company says “emerging research” suggests that selenium might reduce the risk of prostate cancer, the Center said.
“Did you know that there are more new cases of prostate cancer each year than any other cancer?” according to one radio ad. “Now there is something you can do.”
The Center states that a seven-year, $118 million study funded by the National Institute of Health found last year that selenium does not prevent prostate cancer in men.
For more information, see the article from CNN at: http://www.cnn.com/2009/HEALTH/06/18/bayer.vitamins.lawsuit.cancer/index.html?eref=rss_health